Economic value of ribociclib in early breast cancer in the United States.
Saved in:
| Title: | Economic value of ribociclib in early breast cancer in the United States. |
|---|---|
| Authors: | Brufsky A; Department of Medicine, Hematology/Oncology, University of Pittsburgh School of Medicine, PA., Tolaney SM; Dana-Farber Cancer Institute, Boston, MA., Gadi VK; University of Illinois Cancer Center, Chicago., Chai X; Analysis Group, Inc., Boston, MA., Yang F; Analysis Group, Inc., Boston, MA., Chen W; Analysis Group, Inc., Boston, MA., Ma W; Analysis Group, Inc., Boston, MA., Zhou ZY; Analysis Group, Inc., Boston, MA., Ganapathy V; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Patel A; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Sopher G; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Alexander E; Novartis Ireland Ltd., Dublin, Ireland., Bollu V; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Garrison LP Jr; The CHOICE Institute, Department of Pharmacy, University of Washington, Seattle., Sparano JA; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. |
| Source: | Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2026 Aug; Vol. 32 (8), pp. 911-922. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42504809 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Economic value of ribociclib in early breast cancer in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Brufsky+A%22">Brufsky A</searchLink>; Department of Medicine, Hematology/Oncology, University of Pittsburgh School of Medicine, PA.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gadi+VK%22">Gadi VK</searchLink>; University of Illinois Cancer Center, Chicago.<br /><searchLink fieldCode="AU" term="%22Chai+X%22">Chai X</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yang+F%22">Yang F</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ma+W%22">Ma W</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Zhou+ZY%22">Zhou ZY</searchLink>; Analysis Group, Inc., Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ganapathy+V%22">Ganapathy V</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ.<br /><searchLink fieldCode="AU" term="%22Sopher+G%22">Sopher G</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ.<br /><searchLink fieldCode="AU" term="%22Alexander+E%22">Alexander E</searchLink>; Novartis Ireland Ltd., Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Bollu+V%22">Bollu V</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ.<br /><searchLink fieldCode="AU" term="%22Garrison+LP+Jr%22">Garrison LP Jr</searchLink>; The CHOICE Institute, Department of Pharmacy, University of Washington, Seattle.<br /><searchLink fieldCode="AU" term="%22Sparano+JA%22">Sparano JA</searchLink>; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101644425%22">Journal of managed care & specialty pharmacy</searchLink> [J Manag Care Spec Pharm] 2026 Aug; Vol. 32 (8), pp. 911-922. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academy+of+Managed+Care+Pharmacy%22">Academy of Managed Care Pharmacy </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101644425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2376-1032 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223760540%22">23760540 </searchLink><i>NLM ISO Abbreviation: </i>J Manag Care Spec Pharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42504809 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18553/jmcp.2026.32.8.911 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 911 Titles: – TitleFull: Economic value of ribociclib in early breast cancer in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brufsky A – PersonEntity: Name: NameFull: Tolaney SM – PersonEntity: Name: NameFull: Gadi VK – PersonEntity: Name: NameFull: Chai X – PersonEntity: Name: NameFull: Yang F – PersonEntity: Name: NameFull: Chen W – PersonEntity: Name: NameFull: Ma W – PersonEntity: Name: NameFull: Zhou ZY – PersonEntity: Name: NameFull: Ganapathy V – PersonEntity: Name: NameFull: Patel A – PersonEntity: Name: NameFull: Sopher G – PersonEntity: Name: NameFull: Alexander E – PersonEntity: Name: NameFull: Bollu V – PersonEntity: Name: NameFull: Garrison LP Jr – PersonEntity: Name: NameFull: Sparano JA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2376-1032 Numbering: – Type: volume Value: 32 – Type: issue Value: 8 Titles: – TitleFull: Journal of managed care & specialty pharmacy Type: main |
| ResultId | 1 |